IgG4-связанное заболевание: что мы знаем 20 лет спустя - Журнал Терапевтический архив №5 Вопросы ревматологии 2020
IgG4-связанное заболевание: что мы знаем 20 лет спустя
Сокол Е.В. IgG4-связанное заболевание: что мы знаем 20 лет спустя. Терапевтический архив. 2020; 92 (5): 104–109. DOI: 10.26442/00403660.2020.05.000632
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
IgG4-связанное заболевание (IgG4-CЗ) – системное иммуноопосредованное фибровоспалительное заболевание с опухолеподобным характером поражений органов, характеризующееся характерной патоморфологической картиной и гиперсекрецией IgG4 в сыворотке и тканях большинства пациентов. Как отдельная нозологическая единица IgG4-CЗ сформировалось лишь в начале 2000 г. В обзоре рассматривается эволюция взглядов на этиологию и патогенез заболевания, подходы к его диагностике, классификации и лечению.
Ключевые слова: IgG4-связанное заболевание, диагностические критерии, классификационные критерии, патогенез, CD4+ цитотоксические Т-лимфоциты, плазмабласты, злокачественные новообразования, лимфома, аллергия, абатацепт, ритуксимаб.
Key words: IgG4-related disease, diagnostic criteria, classification criteria, pathogenesis, СD4+ T cytotoxic cells, plasmabalsts, malignancy, lymphoma, allergy, abatacept, rituximab.
Ключевые слова: IgG4-связанное заболевание, диагностические критерии, классификационные критерии, патогенез, CD4+ цитотоксические Т-лимфоциты, плазмабласты, злокачественные новообразования, лимфома, аллергия, абатацепт, ритуксимаб.
________________________________________________
Key words: IgG4-related disease, diagnostic criteria, classification criteria, pathogenesis, СD4+ T cytotoxic cells, plasmabalsts, malignancy, lymphoma, allergy, abatacept, rituximab.
Список литературы
1. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012 Feb 9;366(6):539-51. doi: 10.1056/NEJMra1104650
2. Wallace ZS, Perugino C, Matza M, et al. Immunoglobulin G4–related Disease. Clin Chest Med. 2019;583-97. doi: 10.1016/j.ccm.2019.05.005
3. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001 Mar 8;344(10):732-8.
4. Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012 Oct;64(10):3061-7. doi: 10.1002/art.34593
5. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012 Sep;25(9):1181-92. doi: 10.1038/modpathol.2012.72
6. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012 Feb;22(1):21-30. doi: 10.1007/s10165-011-0571-z
7. Wallace ZS, Zhang Y, Perugino CA, et al; ACR/EULAR IgG4-RD Classification Criteria Committee. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019 Mar;78(3):406-12. doi: 10.1136/annrheumdis-2018-214603
8. Masamune A, Kikuta K, Hamada S, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol. 2019 Dec 23. doi: 10.1007/s00535-019-01658-7
9. Сокол Е.В., Васильев В.И., Пальшина С.Г. и др. Клинико-лабораторная характеристика IgG4-связанного заболевания и алгоритм его диагностики. Терапевтический архив. 2019;91(5):40-8 [Sokol EV, Vasilyev VI, Palshina SG, et al. Clinical and laboratory characteristics of IgG4-realated disease and its diagnostic algorithm. Therapeutic Archive. 2019;91(5):40-8 (In Russ.)]. doi: 10.26442/00403660.2019.05.000236
10. Wang L, Zhang P, Wang M, et al. Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients. Arthritis Res Ther. 2018 Apr 10;20(1):65. doi: 10.1186/s13075-018-1567-2
11. Pillai S, Perugino C, Kaneko N. Immune mechanisms of fibrosis and inflammation in IgG4-related disease. Curr Opin Rheumatol. 2019 Dec 13. doi: 10.1097/BOR.0000000000000686
12. de Buy Wenniger LJ1, Culver EL, Beuers U. Exposure to occupational antigens might predispose to IgG4-related disease. Hepatology. 2014 Oct;60(4):1453-4. doi: 10.1002/hep.26999
13. Седышев C.Х., Васильев В.И., Ковригина А.М., Насонов Е.Л. IgG4-связанное системное заболевание. Современный взгляд на «старые» болезни. Научно-практическая ревматология. 2012;54(5):64-72 [Sedyshev SH, Vasilyev VI, Kovrigina AM, Nasonov EL. IgG4-related systemic disease. Contemporary view on "old" diseases. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2012;54(5):64-72 (In Russ.)].
14. Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010 Feb;34(2):202-10. doi: 10.1097/PAS.0b013e3181c811ad
15. Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J Gastroenterol. 2007 May;42(Suppl.)18:39-41. doi: 10.1007/s00535-007-2046-8
16. Kanno A, Masamune A, Okazaki K, et al; Research Committee of Intractable Diseases of the Pancreas. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas. 2015 May;44(4):535-9. doi: 10.1097/MPA.0000000000000325
17. Shimosegawa T, Chari ST, Frulloni L, et al; International Association of Pancreatology. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011 Apr;40(3):352-8. doi: 10.1097/MPA.0b013e3182142fd2
18. Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015 Jan;74(1):14-8. doi: 10.1136/annrheumdis-2013-204907
19. Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol. 2011 Mar;64(3):237-43. doi: 10.1136/jcp.2010.085613
20. Сокол Е.В., Черкасова М.В., Торгашина А.В. Диагностическая ценность IgG4 сыворотки крови при IgG4-связанном заболевании: так ли она велика? Современная ревматология. 2019;13(1):52-7 [Sokol EV, Cherkasova MV, Torgashina AV. The diagnostic value of serum IgG4 for the diagnosis of IgG4-related disease: andis that so great? Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2019;13(1):52-7 (In Russ.)]. doi: 10.14412/1996-7012-2019-1-52-57
21. Khosroshahi, A. Cheryk LA, Carruthers MN, et al. Brief Report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol. 2014 Jan;66(1):213-7. doi: 10.1002/art.38193
22. Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015 Jan;74(1):190-5. doi: 10.1136/annrheumdis-2014-205233
23. Wallace ZS, Naden RP, Chari S, et al; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561
24. Koizumi S, Kamisawa T, Kuruma S, et al. Immunoglobulin G4-related gastrointestinal diseases, are they immunoglobulin G4-related diseases? World J Gastroenterol. 2013 Sep 21;19(35):5769-74. doi: 10.3748/wjg.v19.i35.5769
25. Sasaki T, Yajima T, Shimaoka T, et al. Synergistic effect of IgG4 antibody and CTLs causes tissue inflammation in IgG4-related disease. Int Immunol. 2019 Nov 12. pii: dxz073. doi: 10.1093/intimm/dxz073
26. Mattoo H, Stone JH, Pillai S. Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease. Autoimmunity. 2017 Feb;50(1):19-24. doi: 10.1080/08916934
27. Shiokawa M, Kodama Y, Kuriyama K, et al. Pathogenicity of IgG in patients with IgG4-related disease. Gut. 2016 Aug;65(8):1322-32. doi: 10.1136/gutjnl-2015-310336
28. Perugino CA, Mattoo H, Mahajan VS, et al. Emerging Treatment Models in Rheumatology: IgG4-Related Disease: Insights Into Human Immunology and Targeted Therapies. Arthritis Rheumatol. 2017 Sep;69(9):1722-32. doi: 10.1002/art.40168
29. Pillai S. T and B lymphocytes in fibrosis and systemic sclerosis. Curr Opin Rheumatol. 2019 Nov;31(6):576-81. doi: 10.1097/BOR.0000000000000644
30. Mattoo H, Mahajan VS, Della-Torre E, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014 Sep;134(3):679-87. doi: 10.1016/j.jaci.2014.03.034
31. Miyabe K, Zen Y, Cornell LD, et al. Gastrointestinal and Extra-Intestinal Manifestations of IgG4–Related Disease. Gastroenterology. 2018 Oct;155(4):990-1003.e1. doi: 10.1053/j.gastro.2018.06.082
32. Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015 Apr;94(15):e680. doi: 10.1097/MD.0000000000000680
33. Васильев В.И., Сафонова Т.Н., Сокол Е.В. и др. Диагностика IgG4-связанного офтальмологического заболевания в группе больных с различными поражениями глаз и области орбит. Терапевтический архив. 2018;90(5):61-71 [Vasilyev VI, Safonova TN, Socol EV, et al. Diagnosis of IgG4-related ophthalmic disease in a group of patients with various lesions of the eye and orbits. Therapeutic Archive. 2018;90(5):61-71 (In Russ.)]. doi: 10.26442/terarkh2018905671-71
34. Васильев В.И., Сокол Е.В., Родионова Е.Б. и др. Связанные с IgG-4 поражения слюнных желез. Терапевтический архив. 2015;87(8):92-102 [Vasilyev VI, Sokol EV, Rodionova EB, et al. IgG4-related salivary gland lesions. Therapeutic Archive. 2015;87(8):92-102 (In Russ.)]. doi: 10.17116/terarkh201587892-102
35. Della-Torre E, Mattoo H, Mahajan VS, et al. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy. 2014 Feb;69(2):269-72. doi: 10.1111/all.12320
36. Hong X, Sun ZP, Li W, Chen Y, Gao Y, Su JZ et al. Comorbid diseases of IgG4-related sialadenitis in the head and neck region. Laryngoscope. 2015 Sep;125(9):2113-8. doi: 10.1002/lary.25387.
37. Сокол Е.В., Васильев В.И., Ковригина А.М. и др. Связанное с IgG4 заболевание и В-клеточная клональная лимфоидная полиферация: описание двух клинических случаев и обзор литературы. Терапевтический архив. 2015;87(12):77-84 [Sokol EV, Vasilyev VI, Kovrigina AM, et al. IgG4-related disease and clonal B-cell lymphoid proliferation: description of two clinical cases and review of literature. Therapeutic Archive. 2015;87(12):77-84 (In Russ.)]. doi: 10.17116/
terarkh2015871277-84oi:10.17116/terarkh2015871277-84
38. Казанцева И.А., Лищук С.В., Грибунов Ю.П. и др. Сочетание рака желудка с IgG4-связанной болезнью (клиническое наблюдение и обзор литературы). Архив патологии. 2016;78(4):43-7 [Kazantse-
va IA, Lishchuk SV, Gribiv YuP, et al. Gastric cancer concurrent with IgG4-related disease: A clinical case and a review of literature. Archive patologii. 2016;78(4):43-7 (In Russ.)]. doi: 10.17116/
patol201678443-47
39. Wallace ZS, Wallace CJ, Lu N, et al. Stone JH. Association of IgG4-Related Disease With History of Malignancy. Arthritis Rheumatol. 2016 Sep;68(9):2283-9. doi: 10.1002/art.39773
40. Sato Y, Ohshima K, Takata K, et al. Ocular adnexal IgG4-producing mucosa-associated lymphoid tissue lymphoma mimicking IgG4-related disease. J Clin Exp Hematop. 2012;52(1):51-5.
41. Cheuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacry-oadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg
Pathol. 2008 Aug;32(8):1159-67. doi: 10.1097/PAS.0b013e31816148ad
42. Yamamoto M, Takahashi H, Tabeya T, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012 Jun;22(3):414-8. doi: 10.1007/s10165-011-0520-x
43. Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013 Apr;108(4):610-7. doi: 10.1038/ajg.2012.465
44. Hart PA, Law RJ, Dierkhising RA, et al. Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature. Pancreas. 2014 Apr;43(3):417-21. doi: 10.1097/MPA.0000000000000053
45. Hirano K, Tada M, Sasahira N, et al. Incidence of malignancies in patients with IgG4-related disease. Intern Med. 2014;53(3):171-6.
46. Carruthers MN, Topazian MD, Khosroshahi A, et al.. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015 Jun;74(6):1171-7. doi: 10.1136/annrheumdis-2014-206605
47. Khosroshahi A, Wallace ZS, Crowe JL, et al. Second International Symposium on IgG4-Related Disease International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015 Jul;67(7):1688-99. doi: 10.1002/art.39132
48. Сокол Е.В., Васильев В.И. Лечение IgG4-связанного заболевания. Научно-практическая ревматология. 2016; 54(3): 352-60 [Sokol EV, Vasilyev VI. Treatment of IgG4-related disease. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016; 54(3):352-60 (In Russ.)]. doi: 10.14412/1995-4484-2016-352-360
2. Wallace ZS, Perugino C, Matza M, et al. Immunoglobulin G4–related Disease. Clin Chest Med. 2019;583-97. doi: 10.1016/j.ccm.2019.05.005
3. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001 Mar 8;344(10):732-8.
4. Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012 Oct;64(10):3061-7. doi: 10.1002/art.34593
5. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012 Sep;25(9):1181-92. doi: 10.1038/modpathol.2012.72
6. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012 Feb;22(1):21-30. doi: 10.1007/s10165-011-0571-z
7. Wallace ZS, Zhang Y, Perugino CA, et al; ACR/EULAR IgG4-RD Classification Criteria Committee. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019 Mar;78(3):406-12. doi: 10.1136/annrheumdis-2018-214603
8. Masamune A, Kikuta K, Hamada S, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol. 2019 Dec 23. doi: 10.1007/s00535-019-01658-7
9. Sokol EV, Vasilyev VI, Palshina SG, et al. Clinical and laboratory characteristics of IgG4-realated disease and its diagnostic algorithm. Therapeutic Archive. 2019;91(5):40-8 (In Russ.) doi: 10.26442/00403660.2019.05.000236
10. Wang L, Zhang P, Wang M, et al. Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients. Arthritis Res Ther. 2018 Apr 10;20(1):65. doi: 10.1186/s13075-018-1567-2
11. Pillai S, Perugino C, Kaneko N. Immune mechanisms of fibrosis and inflammation in IgG4-related disease. Curr Opin Rheumatol. 2019 Dec 13. doi: 10.1097/BOR.0000000000000686
12. de Buy Wenniger LJ1, Culver EL, Beuers U. Exposure to occupational antigens might predispose to IgG4-related disease. Hepatology. 2014 Oct;60(4):1453-4. doi: 10.1002/hep.26999
13. Sedyshev SH, Vasilyev VI, Kovrigina AM, Nasonov EL. IgG4-related systemic disease. Contemporary view on "old" diseases. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2012;54(5):64-72 (In Russ.)
14. Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010 Feb;34(2):202-10. doi: 10.1097/PAS.0b013e3181c811ad
15. Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J Gastroenterol. 2007 May;42(Suppl.)18:39-41. doi: 10.1007/s00535-007-2046-8
16. Kanno A, Masamune A, Okazaki K, et al; Research Committee of Intractable Diseases of the Pancreas. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas. 2015 May;44(4):535-9. doi: 10.1097/MPA.0000000000000325
17. Shimosegawa T, Chari ST, Frulloni L, et al; International Association of Pancreatology. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011 Apr;40(3):352-8. doi: 10.1097/MPA.0b013e3182142fd2
18. Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015 Jan;74(1):14-8. doi: 10.1136/annrheumdis-2013-204907
19. Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol. 2011 Mar;64(3):237-43. doi: 10.1136/jcp.2010.085613
20. Sokol EV, Cherkasova MV, Torgashina AV. The diagnostic value of serum IgG4 for the diagnosis of IgG4-related disease: andis that so great? Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2019;13(1):52-7 (In Russ.) doi: 10.14412/1996-7012-2019-1-52-57
21. Khosroshahi, A. Cheryk LA, Carruthers MN, et al. Brief Report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol. 2014 Jan;66(1):213-7. doi: 10.1002/art.38193
22. Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015 Jan;74(1):190-5. doi: 10.1136/annrheumdis-2014-205233
23. Wallace ZS, Naden RP, Chari S, et al; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561
24. Koizumi S, Kamisawa T, Kuruma S, et al. Immunoglobulin G4-related gastrointestinal diseases, are they immunoglobulin G4-related diseases? World J Gastroenterol. 2013 Sep 21;19(35):5769-74. doi: 10.3748/wjg.v19.i35.5769
25. Sasaki T, Yajima T, Shimaoka T, et al. Synergistic effect of IgG4 antibody and CTLs causes tissue inflammation in IgG4-related disease. Int Immunol. 2019 Nov 12. pii: dxz073. doi: 10.1093/intimm/dxz073
26. Mattoo H, Stone JH, Pillai S. Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease. Autoimmunity. 2017 Feb;50(1):19-24. doi: 10.1080/08916934
27. Shiokawa M, Kodama Y, Kuriyama K, et al. Pathogenicity of IgG in patients with IgG4-related disease. Gut. 2016 Aug;65(8):1322-32. doi: 10.1136/gutjnl-2015-310336
28. Perugino CA, Mattoo H, Mahajan VS, et al. Emerging Treatment Models in Rheumatology: IgG4-Related Disease: Insights Into Human Immunology and Targeted Therapies. Arthritis Rheumatol. 2017 Sep;69(9):1722-32. doi: 10.1002/art.40168
29. Pillai S. T and B lymphocytes in fibrosis and systemic sclerosis. Curr Opin Rheumatol. 2019 Nov;31(6):576-81. doi: 10.1097/BOR.0000000000000644
30. Mattoo H, Mahajan VS, Della-Torre E, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014 Sep;134(3):679-87. doi: 10.1016/j.jaci.2014.03.034
31. Miyabe K, Zen Y, Cornell LD, et al. Gastrointestinal and Extra-Intestinal Manifestations of IgG4–Related Disease. Gastroenterology. 2018 Oct;155(4):990-1003.e1. doi: 10.1053/j.gastro.2018.06.082
32. Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015 Apr;94(15):e680. doi: 10.1097/MD.0000000000000680
33. Vasilyev VI, Safonova TN, Socol EV, et al. Diagnosis of IgG4-related ophthalmic disease in a group of patients with various lesions of the eye and orbits. Therapeutic Archive. 2018;90(5):61-71 (In Russ.) doi: 10.26442/terarkh2018905671-71
34. Vasilyev VI, Sokol EV, Rodionova EB, et al. IgG4-related salivary gland lesions. Therapeutic Archive. 2015;87(8):92-102 (In Russ.) doi: 10.17116/terarkh201587892-102
35. Della-Torre E, Mattoo H, Mahajan VS, et al. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy. 2014 Feb;69(2):269-72. doi: 10.1111/all.12320
36. Hong X, Sun ZP, Li W, Chen Y, Gao Y, Su JZ et al. Comorbid diseases of IgG4-related sialadenitis in the head and neck region. Laryngoscope. 2015 Sep;125(9):2113-8. doi: 10.1002/lary.25387.
37. Sokol EV, Vasilyev VI, Kovrigina AM, et al. IgG4-related disease and clonal B-cell lymphoid proliferation: description of two clinical cases and review of literature. Therapeutic Archive. 2015;87(12):77-84 (In Russ.) doi: 10.17116/
terarkh2015871277-84oi:10.17116/terarkh2015871277-84
38. Kazantseva IA, Lishchuk SV, Gribiv YuP, et al. Gastric cancer concurrent with IgG4-related disease: A clinical case and a review of literature. Archive patologii. 2016;78(4):43-7 (In Russ.) doi: 10.17116/patol201678443-47
39. Wallace ZS, Wallace CJ, Lu N, et al. Stone JH. Association of IgG4-Related Disease With History of Malignancy. Arthritis Rheumatol. 2016 Sep;68(9):2283-9. doi: 10.1002/art.39773
40. Sato Y, Ohshima K, Takata K, et al. Ocular adnexal IgG4-producing mucosa-associated lymphoid tissue lymphoma mimicking IgG4-related disease. J Clin Exp Hematop. 2012;52(1):51-5.
41. Cheuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacry-oadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg
Pathol. 2008 Aug;32(8):1159-67. doi: 10.1097/PAS.0b013e31816148ad
42. Yamamoto M, Takahashi H, Tabeya T, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012 Jun;22(3):414-8. doi: 10.1007/s10165-011-0520-x
43. Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013 Apr;108(4):610-7. doi: 10.1038/ajg.2012.465
44. Hart PA, Law RJ, Dierkhising RA, et al. Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature. Pancreas. 2014 Apr;43(3):417-21. doi: 10.1097/MPA.0000000000000053
45. Hirano K, Tada M, Sasahira N, et al. Incidence of malignancies in patients with IgG4-related disease. Intern Med. 2014;53(3):171-6.
46. Carruthers MN, Topazian MD, Khosroshahi A, et al.. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015 Jun;74(6):1171-7. doi: 10.1136/annrheumdis-2014-206605
47. Khosroshahi A, Wallace ZS, Crowe JL, et al. Second International Symposium on IgG4-Related Disease International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015 Jul;67(7):1688-99. doi: 10.1002/art.39132
48. Sokol EV, Vasilyev VI. Treatment of IgG4-related disease. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016; 54(3):352-60 (In Russ.) doi: 10.14412/1995-4484-2016-352-360
2. Wallace ZS, Perugino C, Matza M, et al. Immunoglobulin G4–related Disease. Clin Chest Med. 2019;583-97. doi: 10.1016/j.ccm.2019.05.005
3. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001 Mar 8;344(10):732-8.
4. Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012 Oct;64(10):3061-7. doi: 10.1002/art.34593
5. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012 Sep;25(9):1181-92. doi: 10.1038/modpathol.2012.72
6. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012 Feb;22(1):21-30. doi: 10.1007/s10165-011-0571-z
7. Wallace ZS, Zhang Y, Perugino CA, et al; ACR/EULAR IgG4-RD Classification Criteria Committee. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019 Mar;78(3):406-12. doi: 10.1136/annrheumdis-2018-214603
8. Masamune A, Kikuta K, Hamada S, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol. 2019 Dec 23. doi: 10.1007/s00535-019-01658-7
9. Сокол Е.В., Васильев В.И., Пальшина С.Г. и др. Клинико-лабораторная характеристика IgG4-связанного заболевания и алгоритм его диагностики. Терапевтический архив. 2019;91(5):40-8 [Sokol EV, Vasilyev VI, Palshina SG, et al. Clinical and laboratory characteristics of IgG4-realated disease and its diagnostic algorithm. Therapeutic Archive. 2019;91(5):40-8 (In Russ.)]. doi: 10.26442/00403660.2019.05.000236
10. Wang L, Zhang P, Wang M, et al. Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients. Arthritis Res Ther. 2018 Apr 10;20(1):65. doi: 10.1186/s13075-018-1567-2
11. Pillai S, Perugino C, Kaneko N. Immune mechanisms of fibrosis and inflammation in IgG4-related disease. Curr Opin Rheumatol. 2019 Dec 13. doi: 10.1097/BOR.0000000000000686
12. de Buy Wenniger LJ1, Culver EL, Beuers U. Exposure to occupational antigens might predispose to IgG4-related disease. Hepatology. 2014 Oct;60(4):1453-4. doi: 10.1002/hep.26999
13. Седышев C.Х., Васильев В.И., Ковригина А.М., Насонов Е.Л. IgG4-связанное системное заболевание. Современный взгляд на «старые» болезни. Научно-практическая ревматология. 2012;54(5):64-72 [Sedyshev SH, Vasilyev VI, Kovrigina AM, Nasonov EL. IgG4-related systemic disease. Contemporary view on "old" diseases. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2012;54(5):64-72 (In Russ.)].
14. Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010 Feb;34(2):202-10. doi: 10.1097/PAS.0b013e3181c811ad
15. Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J Gastroenterol. 2007 May;42(Suppl.)18:39-41. doi: 10.1007/s00535-007-2046-8
16. Kanno A, Masamune A, Okazaki K, et al; Research Committee of Intractable Diseases of the Pancreas. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas. 2015 May;44(4):535-9. doi: 10.1097/MPA.0000000000000325
17. Shimosegawa T, Chari ST, Frulloni L, et al; International Association of Pancreatology. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011 Apr;40(3):352-8. doi: 10.1097/MPA.0b013e3182142fd2
18. Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015 Jan;74(1):14-8. doi: 10.1136/annrheumdis-2013-204907
19. Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol. 2011 Mar;64(3):237-43. doi: 10.1136/jcp.2010.085613
20. Сокол Е.В., Черкасова М.В., Торгашина А.В. Диагностическая ценность IgG4 сыворотки крови при IgG4-связанном заболевании: так ли она велика? Современная ревматология. 2019;13(1):52-7 [Sokol EV, Cherkasova MV, Torgashina AV. The diagnostic value of serum IgG4 for the diagnosis of IgG4-related disease: andis that so great? Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2019;13(1):52-7 (In Russ.)]. doi: 10.14412/1996-7012-2019-1-52-57
21. Khosroshahi, A. Cheryk LA, Carruthers MN, et al. Brief Report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol. 2014 Jan;66(1):213-7. doi: 10.1002/art.38193
22. Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015 Jan;74(1):190-5. doi: 10.1136/annrheumdis-2014-205233
23. Wallace ZS, Naden RP, Chari S, et al; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561
24. Koizumi S, Kamisawa T, Kuruma S, et al. Immunoglobulin G4-related gastrointestinal diseases, are they immunoglobulin G4-related diseases? World J Gastroenterol. 2013 Sep 21;19(35):5769-74. doi: 10.3748/wjg.v19.i35.5769
25. Sasaki T, Yajima T, Shimaoka T, et al. Synergistic effect of IgG4 antibody and CTLs causes tissue inflammation in IgG4-related disease. Int Immunol. 2019 Nov 12. pii: dxz073. doi: 10.1093/intimm/dxz073
26. Mattoo H, Stone JH, Pillai S. Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease. Autoimmunity. 2017 Feb;50(1):19-24. doi: 10.1080/08916934
27. Shiokawa M, Kodama Y, Kuriyama K, et al. Pathogenicity of IgG in patients with IgG4-related disease. Gut. 2016 Aug;65(8):1322-32. doi: 10.1136/gutjnl-2015-310336
28. Perugino CA, Mattoo H, Mahajan VS, et al. Emerging Treatment Models in Rheumatology: IgG4-Related Disease: Insights Into Human Immunology and Targeted Therapies. Arthritis Rheumatol. 2017 Sep;69(9):1722-32. doi: 10.1002/art.40168
29. Pillai S. T and B lymphocytes in fibrosis and systemic sclerosis. Curr Opin Rheumatol. 2019 Nov;31(6):576-81. doi: 10.1097/BOR.0000000000000644
30. Mattoo H, Mahajan VS, Della-Torre E, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014 Sep;134(3):679-87. doi: 10.1016/j.jaci.2014.03.034
31. Miyabe K, Zen Y, Cornell LD, et al. Gastrointestinal and Extra-Intestinal Manifestations of IgG4–Related Disease. Gastroenterology. 2018 Oct;155(4):990-1003.e1. doi: 10.1053/j.gastro.2018.06.082
32. Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015 Apr;94(15):e680. doi: 10.1097/MD.0000000000000680
33. Васильев В.И., Сафонова Т.Н., Сокол Е.В. и др. Диагностика IgG4-связанного офтальмологического заболевания в группе больных с различными поражениями глаз и области орбит. Терапевтический архив. 2018;90(5):61-71 [Vasilyev VI, Safonova TN, Socol EV, et al. Diagnosis of IgG4-related ophthalmic disease in a group of patients with various lesions of the eye and orbits. Therapeutic Archive. 2018;90(5):61-71 (In Russ.)]. doi: 10.26442/terarkh2018905671-71
34. Васильев В.И., Сокол Е.В., Родионова Е.Б. и др. Связанные с IgG-4 поражения слюнных желез. Терапевтический архив. 2015;87(8):92-102 [Vasilyev VI, Sokol EV, Rodionova EB, et al. IgG4-related salivary gland lesions. Therapeutic Archive. 2015;87(8):92-102 (In Russ.)]. doi: 10.17116/terarkh201587892-102
35. Della-Torre E, Mattoo H, Mahajan VS, et al. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy. 2014 Feb;69(2):269-72. doi: 10.1111/all.12320
36. Hong X, Sun ZP, Li W, Chen Y, Gao Y, Su JZ et al. Comorbid diseases of IgG4-related sialadenitis in the head and neck region. Laryngoscope. 2015 Sep;125(9):2113-8. doi: 10.1002/lary.25387.
37. Сокол Е.В., Васильев В.И., Ковригина А.М. и др. Связанное с IgG4 заболевание и В-клеточная клональная лимфоидная полиферация: описание двух клинических случаев и обзор литературы. Терапевтический архив. 2015;87(12):77-84 [Sokol EV, Vasilyev VI, Kovrigina AM, et al. IgG4-related disease and clonal B-cell lymphoid proliferation: description of two clinical cases and review of literature. Therapeutic Archive. 2015;87(12):77-84 (In Russ.)]. doi: 10.17116/
terarkh2015871277-84oi:10.17116/terarkh2015871277-84
38. Казанцева И.А., Лищук С.В., Грибунов Ю.П. и др. Сочетание рака желудка с IgG4-связанной болезнью (клиническое наблюдение и обзор литературы). Архив патологии. 2016;78(4):43-7 [Kazantse-
va IA, Lishchuk SV, Gribiv YuP, et al. Gastric cancer concurrent with IgG4-related disease: A clinical case and a review of literature. Archive patologii. 2016;78(4):43-7 (In Russ.)]. doi: 10.17116/
patol201678443-47
39. Wallace ZS, Wallace CJ, Lu N, et al. Stone JH. Association of IgG4-Related Disease With History of Malignancy. Arthritis Rheumatol. 2016 Sep;68(9):2283-9. doi: 10.1002/art.39773
40. Sato Y, Ohshima K, Takata K, et al. Ocular adnexal IgG4-producing mucosa-associated lymphoid tissue lymphoma mimicking IgG4-related disease. J Clin Exp Hematop. 2012;52(1):51-5.
41. Cheuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacry-oadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg
Pathol. 2008 Aug;32(8):1159-67. doi: 10.1097/PAS.0b013e31816148ad
42. Yamamoto M, Takahashi H, Tabeya T, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012 Jun;22(3):414-8. doi: 10.1007/s10165-011-0520-x
43. Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013 Apr;108(4):610-7. doi: 10.1038/ajg.2012.465
44. Hart PA, Law RJ, Dierkhising RA, et al. Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature. Pancreas. 2014 Apr;43(3):417-21. doi: 10.1097/MPA.0000000000000053
45. Hirano K, Tada M, Sasahira N, et al. Incidence of malignancies in patients with IgG4-related disease. Intern Med. 2014;53(3):171-6.
46. Carruthers MN, Topazian MD, Khosroshahi A, et al.. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015 Jun;74(6):1171-7. doi: 10.1136/annrheumdis-2014-206605
47. Khosroshahi A, Wallace ZS, Crowe JL, et al. Second International Symposium on IgG4-Related Disease International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015 Jul;67(7):1688-99. doi: 10.1002/art.39132
48. Сокол Е.В., Васильев В.И. Лечение IgG4-связанного заболевания. Научно-практическая ревматология. 2016; 54(3): 352-60 [Sokol EV, Vasilyev VI. Treatment of IgG4-related disease. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016; 54(3):352-60 (In Russ.)]. doi: 10.14412/1995-4484-2016-352-360
________________________________________________
2. Wallace ZS, Perugino C, Matza M, et al. Immunoglobulin G4–related Disease. Clin Chest Med. 2019;583-97. doi: 10.1016/j.ccm.2019.05.005
3. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001 Mar 8;344(10):732-8.
4. Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012 Oct;64(10):3061-7. doi: 10.1002/art.34593
5. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012 Sep;25(9):1181-92. doi: 10.1038/modpathol.2012.72
6. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012 Feb;22(1):21-30. doi: 10.1007/s10165-011-0571-z
7. Wallace ZS, Zhang Y, Perugino CA, et al; ACR/EULAR IgG4-RD Classification Criteria Committee. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019 Mar;78(3):406-12. doi: 10.1136/annrheumdis-2018-214603
8. Masamune A, Kikuta K, Hamada S, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol. 2019 Dec 23. doi: 10.1007/s00535-019-01658-7
9. Sokol EV, Vasilyev VI, Palshina SG, et al. Clinical and laboratory characteristics of IgG4-realated disease and its diagnostic algorithm. Therapeutic Archive. 2019;91(5):40-8 (In Russ.) doi: 10.26442/00403660.2019.05.000236
10. Wang L, Zhang P, Wang M, et al. Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients. Arthritis Res Ther. 2018 Apr 10;20(1):65. doi: 10.1186/s13075-018-1567-2
11. Pillai S, Perugino C, Kaneko N. Immune mechanisms of fibrosis and inflammation in IgG4-related disease. Curr Opin Rheumatol. 2019 Dec 13. doi: 10.1097/BOR.0000000000000686
12. de Buy Wenniger LJ1, Culver EL, Beuers U. Exposure to occupational antigens might predispose to IgG4-related disease. Hepatology. 2014 Oct;60(4):1453-4. doi: 10.1002/hep.26999
13. Sedyshev SH, Vasilyev VI, Kovrigina AM, Nasonov EL. IgG4-related systemic disease. Contemporary view on "old" diseases. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2012;54(5):64-72 (In Russ.)
14. Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010 Feb;34(2):202-10. doi: 10.1097/PAS.0b013e3181c811ad
15. Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J Gastroenterol. 2007 May;42(Suppl.)18:39-41. doi: 10.1007/s00535-007-2046-8
16. Kanno A, Masamune A, Okazaki K, et al; Research Committee of Intractable Diseases of the Pancreas. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas. 2015 May;44(4):535-9. doi: 10.1097/MPA.0000000000000325
17. Shimosegawa T, Chari ST, Frulloni L, et al; International Association of Pancreatology. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011 Apr;40(3):352-8. doi: 10.1097/MPA.0b013e3182142fd2
18. Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015 Jan;74(1):14-8. doi: 10.1136/annrheumdis-2013-204907
19. Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol. 2011 Mar;64(3):237-43. doi: 10.1136/jcp.2010.085613
20. Sokol EV, Cherkasova MV, Torgashina AV. The diagnostic value of serum IgG4 for the diagnosis of IgG4-related disease: andis that so great? Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2019;13(1):52-7 (In Russ.) doi: 10.14412/1996-7012-2019-1-52-57
21. Khosroshahi, A. Cheryk LA, Carruthers MN, et al. Brief Report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol. 2014 Jan;66(1):213-7. doi: 10.1002/art.38193
22. Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015 Jan;74(1):190-5. doi: 10.1136/annrheumdis-2014-205233
23. Wallace ZS, Naden RP, Chari S, et al; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561
24. Koizumi S, Kamisawa T, Kuruma S, et al. Immunoglobulin G4-related gastrointestinal diseases, are they immunoglobulin G4-related diseases? World J Gastroenterol. 2013 Sep 21;19(35):5769-74. doi: 10.3748/wjg.v19.i35.5769
25. Sasaki T, Yajima T, Shimaoka T, et al. Synergistic effect of IgG4 antibody and CTLs causes tissue inflammation in IgG4-related disease. Int Immunol. 2019 Nov 12. pii: dxz073. doi: 10.1093/intimm/dxz073
26. Mattoo H, Stone JH, Pillai S. Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease. Autoimmunity. 2017 Feb;50(1):19-24. doi: 10.1080/08916934
27. Shiokawa M, Kodama Y, Kuriyama K, et al. Pathogenicity of IgG in patients with IgG4-related disease. Gut. 2016 Aug;65(8):1322-32. doi: 10.1136/gutjnl-2015-310336
28. Perugino CA, Mattoo H, Mahajan VS, et al. Emerging Treatment Models in Rheumatology: IgG4-Related Disease: Insights Into Human Immunology and Targeted Therapies. Arthritis Rheumatol. 2017 Sep;69(9):1722-32. doi: 10.1002/art.40168
29. Pillai S. T and B lymphocytes in fibrosis and systemic sclerosis. Curr Opin Rheumatol. 2019 Nov;31(6):576-81. doi: 10.1097/BOR.0000000000000644
30. Mattoo H, Mahajan VS, Della-Torre E, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014 Sep;134(3):679-87. doi: 10.1016/j.jaci.2014.03.034
31. Miyabe K, Zen Y, Cornell LD, et al. Gastrointestinal and Extra-Intestinal Manifestations of IgG4–Related Disease. Gastroenterology. 2018 Oct;155(4):990-1003.e1. doi: 10.1053/j.gastro.2018.06.082
32. Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015 Apr;94(15):e680. doi: 10.1097/MD.0000000000000680
33. Vasilyev VI, Safonova TN, Socol EV, et al. Diagnosis of IgG4-related ophthalmic disease in a group of patients with various lesions of the eye and orbits. Therapeutic Archive. 2018;90(5):61-71 (In Russ.) doi: 10.26442/terarkh2018905671-71
34. Vasilyev VI, Sokol EV, Rodionova EB, et al. IgG4-related salivary gland lesions. Therapeutic Archive. 2015;87(8):92-102 (In Russ.) doi: 10.17116/terarkh201587892-102
35. Della-Torre E, Mattoo H, Mahajan VS, et al. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy. 2014 Feb;69(2):269-72. doi: 10.1111/all.12320
36. Hong X, Sun ZP, Li W, Chen Y, Gao Y, Su JZ et al. Comorbid diseases of IgG4-related sialadenitis in the head and neck region. Laryngoscope. 2015 Sep;125(9):2113-8. doi: 10.1002/lary.25387.
37. Sokol EV, Vasilyev VI, Kovrigina AM, et al. IgG4-related disease and clonal B-cell lymphoid proliferation: description of two clinical cases and review of literature. Therapeutic Archive. 2015;87(12):77-84 (In Russ.) doi: 10.17116/
terarkh2015871277-84oi:10.17116/terarkh2015871277-84
38. Kazantseva IA, Lishchuk SV, Gribiv YuP, et al. Gastric cancer concurrent with IgG4-related disease: A clinical case and a review of literature. Archive patologii. 2016;78(4):43-7 (In Russ.) doi: 10.17116/patol201678443-47
39. Wallace ZS, Wallace CJ, Lu N, et al. Stone JH. Association of IgG4-Related Disease With History of Malignancy. Arthritis Rheumatol. 2016 Sep;68(9):2283-9. doi: 10.1002/art.39773
40. Sato Y, Ohshima K, Takata K, et al. Ocular adnexal IgG4-producing mucosa-associated lymphoid tissue lymphoma mimicking IgG4-related disease. J Clin Exp Hematop. 2012;52(1):51-5.
41. Cheuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacry-oadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg
Pathol. 2008 Aug;32(8):1159-67. doi: 10.1097/PAS.0b013e31816148ad
42. Yamamoto M, Takahashi H, Tabeya T, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012 Jun;22(3):414-8. doi: 10.1007/s10165-011-0520-x
43. Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013 Apr;108(4):610-7. doi: 10.1038/ajg.2012.465
44. Hart PA, Law RJ, Dierkhising RA, et al. Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature. Pancreas. 2014 Apr;43(3):417-21. doi: 10.1097/MPA.0000000000000053
45. Hirano K, Tada M, Sasahira N, et al. Incidence of malignancies in patients with IgG4-related disease. Intern Med. 2014;53(3):171-6.
46. Carruthers MN, Topazian MD, Khosroshahi A, et al.. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015 Jun;74(6):1171-7. doi: 10.1136/annrheumdis-2014-206605
47. Khosroshahi A, Wallace ZS, Crowe JL, et al. Second International Symposium on IgG4-Related Disease International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015 Jul;67(7):1688-99. doi: 10.1002/art.39132
48. Sokol EV, Vasilyev VI. Treatment of IgG4-related disease. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016; 54(3):352-60 (In Russ.) doi: 10.14412/1995-4484-2016-352-360
Авторы
Е.В. Сокол
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой», Москва, Россия
Nasonova Research Institute of Rheumatology, Moscow, Russia
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой», Москва, Россия
________________________________________________
Nasonova Research Institute of Rheumatology, Moscow, Russia
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.